Koios develops a digital medicine platform focused on neurology, starting with Parkinson's Disease. The platform integrates data, software, and AI to generate clinically meaningful insights from everyday devices for remote patient monitoring. This approach aims to support better care delivery and optimize outcomes for patients, providers, and pharmaceutical research.
Funding
$380.5K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Individuals with neurodegenerative and chronic diseases, such as Parkinson's Disease, require continuous monitoring to optimize treatment plans. Traditional clinical assessments offer only intermittent snapshots of a patient's condition, potentially missing subtle but significant changes in their daily lives that impact quality of life. This lack of continuous data hinders timely intervention and personalized care adjustments.
Solution
Koios Care provides validated digital biomarkers derived from passive monitoring of daily activities, offering continuous insights into the quality of life for individuals with neurodegenerative and chronic diseases. The platform leverages data from everyday devices to track physical activity, sleep quality, social behavior, medication adherence, and meal intake. By analyzing these data streams, Koios Care generates a Quality of Life index and identifies early signs of disease progression. This continuous monitoring enables healthcare providers to optimize treatment plans, improve patient outcomes, and potentially reduce healthcare costs through proactive intervention.
Target Audience
The primary users are pharmaceutical companies seeking to improve data flow and patient engagement, healthcare providers aiming to optimize resource usage, clinical researchers requiring high-quality data, and individuals seeking to practice self-care and manage their disease proactively.
Features
- Continuous, 24/7 passive monitoring of physical activity, sleep quality, social behavior, drug adherence, and meal intake.
- Quality of Life index based on validated digital biomarkers.
- Early-stage and disease progression screening for conditions like Parkinson's Disease.
- Medication effectiveness quantification through activity and behavior analysis.
- Data flow optimized for commercial smartphones and smartwatches.
- High-caliber data flow built for commercial smartphones and smartwatches.